AbbVie‘s hepatitis C drug cured 97 percent of patients who received a liver transplant in a recent trial, according to a Bloomberg report.
Boston Scientific Director Edward J. Ludwig bought 10,000 shares of the company’s stock at an average cost of $13.38 per share for a total transaction of $133,800, according to a WKRB News & Analysis report.
EndoChoice received FDA 510(k) clearance for its Bonastent Tracheal/Bronchial device in October.
Frost & Sullivan awarded Metabolomic Technologies its 2014 North American Frost & Sullivan Award for Technology Innovation Leadership in recognition of the company’s metabolomic screening test PolypDx.
The FDA approved SQI Diagnostics‘ proprietary Celiac Panel in the United States.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
AGA Academy of Educators chooses 4 grant recipients
Medrobotics raises $20 million
Capsule, surgical endoscope market to grow at 13.8% through 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
